He was a board member of Questcor Pharmaceuticals until it was acquired by acquired by Mallinckrodt Pharmaceutics for $5.6 Billion in August 2014 .
A chartered financial analyst ( CFA ) , Bradsher is founder and president of Broadwood Capital .
Bradsher was a founder   of Questcor Pharmaceuticals until it was acquired by acquired by Mallinckrodt Pharmaceutics for $5.6 Billion in August 2014 .
A chartered financial analyst ( CFA ) , Bradsher is founder and president of Broadwood Capital .